atezolizumab
roche
['immotion010', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo']
immotion010: ph iii adjuvant atezo vs placebo for rcc at risk of recurrence after resection atezo vs placebo: dfs: hr 0.93, 95% ci 0.75, 1.15 dfs for pd-l1 ic expression &gt;= 5%: hr 0.57, 95% ci 0.29, 1.15 gr 3/4 aes 27.2% vs 21.1% #esmo22 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday